160 related articles for article (PubMed ID: 29330472)
1. Amyloid deposition in a mouse model humanized at the transthyretin and retinol-binding protein 4 loci.
Li X; Lyu Y; Shen J; Mu Y; Qiang L; Liu L; Araki K; Imbimbo BP; Yamamura KI; Jin S; Li Z
Lab Invest; 2018 Apr; 98(4):512-524. PubMed ID: 29330472
[TBL] [Abstract][Full Text] [Related]
2. CHF5074 (CSP-1103) stabilizes human transthyretin in mice humanized at the transthyretin and retinol-binding protein loci.
Mu Y; Jin S; Shen J; Sugano A; Takaoka Y; Qiang L; Imbimbo BP; Yamamura K; Li Z
FEBS Lett; 2015 Mar; 589(7):849-56. PubMed ID: 25728271
[TBL] [Abstract][Full Text] [Related]
3. Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy.
Kohno K; Palha JA; Miyakawa K; Saraiva MJ; Ito S; Mabuchi T; Blaner WS; Iijima H; Tsukahara S; Episkopou V; Gottesman ME; Shimada K; Takahashi K; Yamamura K; Maeda S
Am J Pathol; 1997 Apr; 150(4):1497-508. PubMed ID: 9095004
[TBL] [Abstract][Full Text] [Related]
4. Identification of Transthyretin Tetramer Kinetic Stabilizers That Are Capable of Inhibiting the Retinol-Dependent Retinol Binding Protein 4-Transthyretin Interaction: Potential Novel Therapeutics for Macular Degeneration, Transthyretin Amyloidosis, and Their Common Age-Related Comorbidities.
Cioffi CL; Raja A; Muthuraman P; Jayaraman A; Jayakumar S; Varadi A; Racz B; Petrukhin K
J Med Chem; 2021 Jul; 64(13):9010-9041. PubMed ID: 34138572
[TBL] [Abstract][Full Text] [Related]
5. Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model.
Cardoso I; Saraiva MJ
FASEB J; 2006 Feb; 20(2):234-9. PubMed ID: 16449795
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Bispecific Antagonists of Retinol Binding Protein 4 That Stabilize Transthyretin Tetramers: Scaffolding Hopping, Optimization, and Preclinical Pharmacological Evaluation as a Potential Therapy for Two Common Age-Related Comorbidities.
Cioffi CL; Muthuraman P; Raja A; Varadi A; Racz B; Petrukhin K
J Med Chem; 2020 Oct; 63(19):11054-11084. PubMed ID: 32878437
[TBL] [Abstract][Full Text] [Related]
7. Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro.
Sousa MM; Fernandes R; Palha JA; Taboada A; Vieira P; Saraiva MJ
Am J Pathol; 2002 Nov; 161(5):1935-48. PubMed ID: 12414539
[TBL] [Abstract][Full Text] [Related]
8. Comparison of amyloid deposition in two lines of transgenic mouse that model familial amyloidotic polyneuropathy, type I.
Takaoka Y; Tashiro F; Yi S; Maeda S; Shimada K; Takahashi K; Sakaki Y; Yamamura K
Transgenic Res; 1997 Jul; 6(4):261-9. PubMed ID: 9232027
[TBL] [Abstract][Full Text] [Related]
9. Amyloid and nonfibrillar deposits in mice transgenic for wild-type human transthyretin: a possible model for senile systemic amyloidosis.
Teng MH; Yin JY; Vidal R; Ghiso J; Kumar A; Rabenou R; Shah A; Jacobson DR; Tagoe C; Gallo G; Buxbaum J
Lab Invest; 2001 Mar; 81(3):385-96. PubMed ID: 11310831
[TBL] [Abstract][Full Text] [Related]
10. TTR kinetic stabilizers and TTR gene silencing: a new era in therapy for familial amyloidotic polyneuropathies.
Adams D; Cauquil C; Labeyrie C; Beaudonnet G; Algalarrondo V; Théaudin M
Expert Opin Pharmacother; 2016; 17(6):791-802. PubMed ID: 26800456
[TBL] [Abstract][Full Text] [Related]
11. Synergy of combined doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse models.
Cardoso I; Martins D; Ribeiro T; Merlini G; Saraiva MJ
J Transl Med; 2010 Jul; 8():74. PubMed ID: 20673327
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice models.
Ferreira N; Saraiva MJ; Almeida MR
PLoS One; 2012; 7(1):e29933. PubMed ID: 22253829
[TBL] [Abstract][Full Text] [Related]
13. Circulating transthyretin and retinol binding protein 4 levels among middle-age V122I
Hendren NS; De Lemos JA; Berry JD; Kozlitina J; Saelices L; Ji AX; Shao Z; Liu CF; Garg S; Farr MA; Drazner MH; Tang WHW; Grodin JL
Amyloid; 2024 Jun; 31(2):124-131. PubMed ID: 38445629
[TBL] [Abstract][Full Text] [Related]
14. Inconsistency between hepatic expression and serum concentration of transthyretin in mice humanized at the transthyretin locus.
Zhao G; Li Z; Araki K; Haruna K; Yamaguchi K; Araki M; Takeya M; Ando Y; Yamamura K
Genes Cells; 2008 Dec; 13(12):1257-68. PubMed ID: 19032346
[TBL] [Abstract][Full Text] [Related]
15. Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade.
Bulawa CE; Connelly S; Devit M; Wang L; Weigel C; Fleming JA; Packman J; Powers ET; Wiseman RL; Foss TR; Wilson IA; Kelly JW; Labaudinière R
Proc Natl Acad Sci U S A; 2012 Jun; 109(24):9629-34. PubMed ID: 22645360
[TBL] [Abstract][Full Text] [Related]
16. CSP-1103 (CHF5074) stabilizes human transthyretin in healthy human subjects.
Qiang L; Guan Y; Li X; Liu L; Mu Y; Sugano A; Takaoka Y; Sakaeda T; Imbimbo BP; Yamamura KI; Jin S; Li Z
Amyloid; 2017 Mar; 24(1):42-51. PubMed ID: 28393633
[TBL] [Abstract][Full Text] [Related]
17. Loss of functional albumin triggers acceleration of transthyretin amyloid fibril formation in familial amyloidotic polyneuropathy.
Kugimiya T; Jono H; Saito S; Maruyama T; Kadowaki D; Misumi Y; Hoshii Y; Tasaki M; Su Y; Ueda M; Obayashi K; Shono M; Otagiri M; Ando Y
Lab Invest; 2011 Aug; 91(8):1219-28. PubMed ID: 21537325
[TBL] [Abstract][Full Text] [Related]
18. Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met30) gene. Pathologic similarity to human familial amyloidotic polyneuropathy, type I.
Yi S; Takahashi K; Naito M; Tashiro F; Wakasugi S; Maeda S; Shimada K; Yamamura K; Araki S
Am J Pathol; 1991 Feb; 138(2):403-12. PubMed ID: 1992765
[TBL] [Abstract][Full Text] [Related]
19. Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice.
Mody N; Graham TE; Tsuji Y; Yang Q; Kahn BB
Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E785-93. PubMed ID: 18285525
[TBL] [Abstract][Full Text] [Related]
20. Familial amyloidotic polyneuropathy: protein aggregation in the peripheral nervous system.
João Saraiva M; Mendes Sousa M; Cardoso I; Fernandes R
J Mol Neurosci; 2004; 23(1-2):35-40. PubMed ID: 15126690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
